HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Revenue
HLS Therapeutics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Revenue
$63.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Revenue
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is HLS Therapeutics Inc's Revenue?
Revenue
63.1m
USD
Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Revenue amounts to 63.1m USD.
What is HLS Therapeutics Inc's Revenue growth rate?
Revenue CAGR 10Y
-3%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for HLS Therapeutics Inc have been 4% over the past three years , 1% over the past five years , and -3% over the past ten years .